Drugs

Treatment of Sepsis: Past and Future Avenues
pp. 127-132(6)
Authors: Baumgartner J-D.; Calandra T.

Clinical and Preclinical Modulation of Chemotherapy-Induced Toxicity in Patients with Cancer
pp. 133-155(23)
Authors: Hoekman K.; J.F. van der Vijgh W.; Vermorken J.B.

Systematic Review of the Treatment of Early Lyme Disease
pp. 157-173(17)
Authors: Loewen P.S.; Marra C.A.; Marra F.

Preventing Postoperative Infections: Current Treatment Recommendations
pp. 175-185(11)
Author: Gyssens I.C.

Current Pharmacological Approaches to the Therapy of Varicella Zoster Virus Infections: A Guide to Treatment
pp. 187-206(20)
Authors: Snoeck R.; Andrei G.; Clercq E.D.

Basiliximab
pp. 207-213(7)
Authors: Onrust S.V.; Wiseman L.R.

Basiliximab: A Viewpoint by Björn Nashan
pp. 214-214(1)
Author: Nashan B.

Basiliximab: A Viewpoint by Giuseppe Remuzzi
pp. 214-214(1)
Author: Remuzzi G.

Lamifiban
pp. 215-221(7)
Authors: Dooley M.; Goa K.L.

Lamifiban: A Viewpoint by Robert A. Harrington
pp. 222-223(2)
Author: Harrington R.A.

Lamifiban: A Viewpoint by David J. Moliterno
pp. 222-223(2)
Author: Moliterno D.J.

Sibrafiban
pp. 225-230(6)
Authors: Dooley M.; Goa K.L.

Sibrafiban: A Viewpoint by Frans J. Van de Werf
pp. 231-232(2)
Author: Van de Werf F.J.

Sibrafiban: A Viewpoint by Christopher P. Cannon
pp. 231-232(2)
Author: Cannon C.P.

Aprotinin: An Update of its Pharmacology and Therapeutic Use in Open Heart Surgery and Coronary Artery Bypass Surgery
pp. 233-260(28)
Authors: Peters D.C.; Noble S.

Isosorbide 5-Mononitrate: A Review of a Sustained-Release Formulation (Imdur) in Stable Angina Pectoris
pp. 261-277(17)
Authors: Gunasekara N.S.; Noble S.